Practice
Clinical updates, guidelines, prescribing, and practical medicine
Pfizer’s Monthly Obesity Drug Shows Promise in Detailed Midstage Trial Data
Detailed midstage trial data provide further evidence that Pfizer's obesity drug berobenatide, acquired from Metsera, could offer effective weight management…
Editor's Top Picks
Eli Lilly Reports Safety Data for Next-Generation Obesity Drug Retatrutide
Eli Lilly presented new safety data for retatrutide, its triple-hormone obesity drug, at the 2026 American Diabetes Association meeting. The…
Submit Your Paper →
More form Practice
Medical Dosing Based on Race Lacks Scientific Evidence and May Harm Patients, NEJM Analysis Warns
New NEJM analysis challenges race-based medication dosing, arguing it lacks scientific foundation and may harm…
NEJM Images Show Advanced Diabetic Eye Disease Progression and Treatment Response
New NEJM clinical images demonstrate proliferative diabetic retinopathy progression, showing characteristic neovascularization of the optic…
Novel PET Tracer Detects Blood Clots in Legs and Lungs with Single Scan
Novel PET radiotracer enables simultaneous detection of deep vein thrombosis and pulmonary embolism in single…
AI-Enhanced Scans and Immune-Targeting Drugs Transform Heart Inflammation Detection
AI-enhanced imaging and immune-targeting drugs are revolutionizing cardiac inflammation detection and treatment. Nature Medicine reports…
Spinal Cord Stimulation Shows Promise for Stroke Recovery in Small Trial
Small clinical trial shows epidural spinal cord stimulation safely improved arm function in seven chronic…